Medigen Vaccines SARS-CoV-2 qPCR Kit obtained CE Marking and Taiwan MOHW’s approval

On Apr. 30, 2020, Medigen Vaccine Biologics (MVC) announced its SARS-CoV-2 qPCR Kit complied with EU CE requirements, completed the EU declaration of conformity and obtained CE marking (IVD) on Apr. 24, 2020. In addition, MVC applied for specific medical devicesﾒ manufacturing in Taiwan.

Tags:

, ,

Source: Medigen Vaccine Biologics
Credit:

Visit News/History Source
Transfection Has Never Been So Easy With Avalanche® Transfection Reagents for Cancer Cells, Primary Cells, And Other Difficult-To-Transfect Cells.Primary Cells, And Other Difficult-To-Transfect Cells.